Clinical Trials
9 trialsNCT06378047 2026-02-09
Irreversible Electroporation & Pembro Immunotherapy in Locally Advanced Pancreatic Cancer
H. Lee Moffitt Cancer Center and Research Institute
Phase 1 Completed
NCT03484299 2025-10-29
Chemotherapy and Irreversible Electroporation in the Treatment of Advanced Pancreatic Adenocarcinoma
University of Louisville
Phase 1 Recruiting
NCT06205849 2025-07-25
Intra-tumoral Mitazalimab (CD40 Antibody) With Irreversible Electroporation (IRE) in Locally Advanced Pancreas Cancer
University of California, San Diego
Phase 1 Recruiting
NCT02531425 2023-05-15
TNBC
OncoSec Medical Incorporated
Phase 1 Completed
NCT04612530 2022-12-20
PANFIRE-3 Trial: Assessing Safety and Efficacy of Irreversible Electroporation (IRE) + Nivolumab + CpG for Metastatic Pancreatic Cancer
Amsterdam UMC, location VUmc
Phase 1 Unknown
NCT04139070 2020-08-20
Electrochemotherapy for Non-curable Gastric Cancer
Zealand University Hospital
Phase 1 Unknown
NCT03051269 2017-02-13
Calcium Electroporation for Head and Neck Cancer
Rigshospitalet, Denmark
Phase 1 Unknown
NCT01045915 2015-09-11
AMEP
Valerio Therapeutics
Phase 1 Terminated
NCT01790451 2015-02-20
Safety and Efficacy of Irreversible Electroporation in Ablation of Prostate Cancer in Humans
Clinical Research Office of the Endourological Society
Phase 1 Completed